Explore By Subject Area   
Return Home
Menu

Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities

Dr Shannon Turley, Genentech, presents on the role of TGF beta, combination therapies and open questions.

January 20, 2023
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities

Summary:

In this podcast, you will hear a presentation from Dr Shannon Turley, Genentech, from the 2021 Immuno-Oncology 360° Conference regarding the role of TGF beta, combination PD L1 + Anti-TCFb therapies and remaining open questions.

To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.

Speakers

Featured Podcasts

Upcoming Conferences

Featured Editorial

Featured Videos & Webcasts

Related Podcasts

View All
Stanford's Dr Crystal Mackall on CAR T for Solid Tumors and Cell Therapy's Future, from IO360º 2025
Stanford's Dr Crystal Mackall on CAR T for Solid Tumors and Cell Therapy's Future, from IO360º 2025
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
2025 Biotech Markets & Immuno-Oncology Outlook
2025 Biotech Markets & Immuno-Oncology Outlook
Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability
Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.